Article Details
Retrieved on: 2024-01-30 12:24:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Barclays PLC's increased investment in BioMarin Pharmaceutical, indicating trust in the company's performance in capital markets, particularly in equity securities and the stock market on exchanges like NASDAQ. The tags reflect the financial and biotech industries, including BioMarin's focus on virotherapy and Elosulfase alfa.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here